The cost of adverse events in metastatic breast cancer in taxane- and capecitabine-based regimens.
Anthony Masaquel
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Ryan N. Hansen
Consultant or Advisory Role - Genentech/Roche
Scott David Ramsey
Consultant or Advisory Role - Genentech/Roche
Deepa Lalla
No relevant relationships to disclose
Melissa Brammer
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Sara A. Hurvitz
Consultant or Advisory Role - Genentech
Sean D. Sullivan
Consultant or Advisory Role - Genentech/Roche